Today: 5 April 2026
Subscribe
Browse Category

Stock Market 17 October 2025 - 18 October 2025

Virgin Galactic Rockets 15% on Space Tourism Buzz – Can SPCE Defy Gravity or Crash Back to Earth?

Virgin Galactic’s Wild October Ride: SPCE Stock Soars on Space Tourism Hype, Then Plummets – What’s Next?

Virgin Galactic shares fell nearly 8% on Oct. 17 to $4.08 after a mid-month rally, leaving the stock down about 33% in 2025 and 99% below all-time highs. The company settled a shareholder lawsuit for $2.9 million in September. It announced a 2027 suborbital research flight with Purdue University. Virgin Galactic reported a $67 million Q2 loss and has about 1.5 years of cash left.
18 October 2025
··
Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat shares plunged nearly 60% in one day, closing at $0.65 on Oct. 17 after a debt-for-equity swap triggered a flood of 316 million new shares. Founder and CEO Ethan Brown resigned from the board as analysts warned of a “death spiral.” The company reported Q2 revenue down 20% year-over-year and a net loss of $33 million. Cash reserves have dwindled to $117 million against $1.2 billion in debt.
18 October 2025
·
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% in one day and 186% in two weeks after announcing progress on its 1-gigawatt AI data center in Texas. The company regained Nasdaq compliance, ended plans for share dilution, and rebranded from helium to AI infrastructure in August. NUAI remains pre-revenue, with $0.7 million in annual sales and steep losses. The stock is up 1300% from its 52-week low.
18 October 2025
····
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Soars 15% to 52-Week High on Psychedelic Breakthrough – What’s Next for MNMD?

MindMed (NASDAQ: MNMD) closed at $13.65 on Oct. 17, up 14.6% in one day and 68% year-to-date, after its LSD-based therapy MM120 showed strong Phase 2b results for Generalized Anxiety Disorder. The FDA granted Breakthrough Therapy status to MM120, with three Phase 3 trials underway. Needham & Co. initiated coverage with a Buy rating and $28 target. MindMed holds $237.9 million in cash, funding operations into 2027.
18 October 2025
··
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Gilead Sciences stock jumped over 4% on Oct. 17, 2025, closing at $122.81 and hitting a new 52-week high. The surge follows a patent settlement extending exclusivity for Biktarvy until 2036 and FDA approval of Yeztugo, a new HIV prevention shot. Gilead’s market cap stands near $150 billion after a 47% year-to-date gain. Analysts remain bullish but note concerns over U.S. drug pricing pressures.
18 October 2025
···
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy (LBRT) Stock Soars 28% on Earnings Surprise – Can the Rally Last?

Liberty Energy Inc. shares surged 28% to $15.32 Friday after quarterly earnings, despite revenue falling 17% year-over-year and an adjusted net loss of $0.06 per share. The company posted a GAAP profit of $43 million due to one-off gains and raised its dividend by 13%. The stock remains well below its early-2025 highs after a steep year-to-date decline. Oilfield activity slowed sharply in 2025, hitting Liberty’s core business.
18 October 2025
···
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Rani Therapeutics shares surged 248% to close at $1.64 on Oct. 17 after announcing a collaboration with Chugai Pharmaceutical worth up to $1.08 billion. The deal includes $10 million upfront and up to $175 million in milestones for the first drug. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. The company’s RaniPill technology delivers injectable drugs via oral capsules.
18 October 2025
···
AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

Tech companies including OpenAI, DeepMind, and Meta are spending over $325 billion by 2025 to develop artificial general intelligence, with leaders predicting AGI could arrive this decade. Some researchers warn superintelligent AI could escape human control and pose existential risks. Nvidia shares surged after a $100 billion investment in OpenAI, while Alphabet’s market value nears $3 trillion amid the AI boom.
18 October 2025
···
Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

The Nasdaq closed at 22,679.98 Friday, up 117 points, capping a volatile week near record highs. Nvidia shares retreated after hitting records, while AMD jumped 34% on an OpenAI chip deal. The KBW Regional Bank Index rebounded after sharp losses as banks addressed loan and fraud concerns. The VIX spiked to a six-month high before easing, with traders bracing for volatility ahead of major tech earnings and a delayed U.S. inflation report.
18 October 2025
·········
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 18.10.2025

Eaton Corporation received an 87% score under Validea’s Peter Lynch P/E/Growth strategy, passing key metrics for growth and valuation. Lululemon Athletica scored 79% in a Buffett-inspired analysis, meeting most fundamental criteria but missing on initial rate of return. Both are classified as large-cap growth stocks.
18 October 2025
·
Boeing’s Turbulent Week: Big Deal Greenlights, Strike Drama, and Hopes of a Comeback

Boeing’s Turbulent Week: Big Deal Greenlights, Strike Drama, and Hopes of a Comeback

The FAA cleared Boeing to raise 737 MAX production to 42 jets monthly, ending a two-year cap. The EU approved Boeing’s $4.7 billion Spirit AeroSystems takeover, requiring divestment of Airbus-linked assets. A 75-day strike in St. Louis delayed F-15EX fighter deliveries. Boeing stock rose 1.5% after the FAA decision; Q2 revenue hit $22.75 billion as losses narrowed.
18 October 2025
··
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed shares hit a 52-week high of $13.09 this week after its LSD-based drug MM120 showed strong Phase 2b results for generalized anxiety disorder and received FDA Breakthrough Therapy designation. The stock is up about 68% year-to-date. Analysts set average price targets near $27.83. MindMed holds $237.9 million in cash, funding operations into 2027.
18 October 2025
··
RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX shares closed at $157.80 on Oct. 17, up 0.5% as the S&P 500 fell. Pratt & Whitney’s new GTF Advantage engine won EASA certification, with commercial entry expected in 2026. Raytheon broke ground on a $53 million expansion to boost LTAMDS radar production amid rising global demand. RTX reports Q3 earnings Oct. 21, with analysts expecting $1.42 EPS on $21.5 billion revenue.
17 October 2025
···
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

IBM shares traded near $276 on Oct. 16, up 28% year-to-date and close to all-time highs. Recent AI and quantum partnerships, along with strong Q2 results—$16.98 billion revenue and $2.80 EPS—have fueled the rally. Analysts remain cautious, with a consensus “Hold” rating and a $280 price target. Q3 earnings are due Oct. 22.
17 October 2025
····
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

Cisco shares traded near $69 on Oct. 17, 2025, close to their 52-week high of $72.55 and up about 30% from a year ago. The company beat earnings expectations with $0.99 EPS and $14.67 billion in revenue, driven by strong AI-related orders and new chip launches. Cisco raised its dividend to $0.41 per share. Wall Street’s consensus rates the stock a “Moderate Buy” with a $74–75 price target.
17 October 2025
···
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s U.S. shares closed near $167 on Oct. 17 after rebounding from early losses, holding an 85% year-to-date gain and trading at four-year highs. The move followed a one-day 8% surge in September and outperformed a 4% drop in Hong Kong shares. Cloud revenue jumped 26% last quarter on AI demand, but heavy investment cut margins. Wall Street remains bullish, with most analysts rating BABA a “Buy.”
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health shares jumped 11% to $21.50 on Oct. 3, 2025, and traded near $21.76 on Oct. 14, up roughly 40% year-to-date. The company announced a $410 million convertible debt offering to fund AI initiatives and launched a new employer health plan with Hy-Vee. Q2 revenue rose to about $2.9 billion, but net losses widened to $228 million. Analysts remain bearish, with an average price target near $12.
17 October 2025
··
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit shares traded around $190 on Oct. 17, down 4.3% for the day and off sharply from a mid-September record near $283. The stock remains up about 244% year-to-date and over 600% since its March 2024 IPO. Q2 revenue jumped 78% to $500 million, with net income at $89 million. Analyst consensus rates the stock a “Moderate Buy,” with a 12-month price target averaging $202.
17 October 2025
1 … 1,303 1,304 1,305 1,306 1,307 … 1,371

Stock Market Today

  • MSCI: AI's Impact on Business Models, Not Business Breakdown
    April 5, 2026, 10:04 AM EDT. MSCI highlights that artificial intelligence (AI) is reshaping business models rather than destroying existing ones. Frank Balestriere, an independent investor and educator with a finance background, emphasizes that AI-driven change alters how companies operate without breaking their core business structures. His research evaluates large-cap stocks with strong competitive advantages and solid management. Balestriere's approach is rooted in fundamental analysis and aims to help long-term investors identify firms capable of wealth compounding. The article reinforces that despite technological shifts, companies with durable moats and high capital reinvestment rates remain valuable. MSCI's view offers a measured perspective amidst rapid AI advancements, supporting investment strategies focused on quality and sustainability.
Go toTop